Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

lifestance health group inc - LFST

LFST

Close Chg Chg %
6.37 -0.06 -0.94%

Closed Market

6.31

-0.06 (0.94%)

Volume: 1.47M

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Trade Now

Company Overview: lifestance health group inc - LFST

LFST Key Data

Open

$6.28

 Day Range

6.21 - 6.36

52 Week Range

3.74 - 8.09

 Market Cap

$2.46B

Shares Outstanding

389.78M

 Public Float

160.56M

Beta

1.13

 Rev. Per Employee

N/A

P/E Ratio

255.47

 EPS

$0.03

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

2.24M

  

LFST Performance

1 Week
 
 -0.16%
 
1 Month
 
 -8.95%
 
3 Months
 
 -9.34%
 
1 Year
 
 -4.97%
 
5 Years
 
 N/A
 

LFST Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 10
Full Ratings ➔

About lifestance health group inc - LFST

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

LFST At a Glance

Lifestance Health Group, Inc.
4800 North Scottsdale Road
Scottsdale, Arizona 85251
Phone 1-602-767-2100 Revenue 1.42B
Industry Medical/Nursing Services Net Income 9.66M
Sector Health Services 2025 Sales Growth 13.854%
Fiscal Year-end 12 / 2026 Employees 10,961
View SEC Filings

LFST Valuation

P/E Current 255.466
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 285.02
Price to Sales Ratio 1.933
Price to Book Ratio 1.797
Price to Cash Flow Ratio 18.84
Enterprise Value to EBITDA 37.031
Enterprise Value to Sales 2.092
Total Debt to Enterprise Value 0.159

LFST Efficiency

Revenue/Employee 129,941.155
Income Per Employee 881.58
Receivables Turnover 14.314
Total Asset Turnover 0.627

LFST Liquidity

Current Ratio 1.652
Quick Ratio 1.652
Cash Ratio 0.987

LFST Profitability

Gross Margin 28.53
Operating Margin 1.805
Pretax Margin 0.868
Net Margin 0.678
Return on Assets 0.425
Return on Equity 0.651
Return on Total Capital 0.484
Return on Invested Capital 0.507

LFST Capital Structure

Total Debt to Total Equity 31.198
Total Debt to Total Capital 23.779
Total Debt to Total Assets 20.484
Long-Term Debt to Equity 27.25
Long-Term Debt to Total Capital 20.77
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Lifestance Health Group Inc - LFST

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
859.54M 1.06B 1.25B 1.42B
Sales Growth
+28.77% +22.82% +18.50% +13.85%
Cost of Goods Sold (COGS) incl D&A
691.72M 834.01M 919.52M 1.02B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
69.20M 80.44M 70.95M 54.75M
Depreciation
28.92M 37.37M 40.68M 41.62M
Amortization of Intangibles
40.28M 43.06M 30.27M 13.13M
COGS Growth
+32.99% +20.57% +10.25% +10.70%
Gross Income
167.82M 221.66M 331.45M 406.35M
Gross Income Growth
+13.87% +32.08% +49.53% +22.60%
Gross Profit Margin
+19.52% +21.00% +26.50% +28.53%
2022 2023 2024 2025 5-year trend
SG&A Expense
373.90M 409.01M 361.91M 380.64M
Research & Development
- - - -
-
Other SG&A
373.90M 409.01M 361.91M 380.64M
SGA Growth
-13.16% +9.39% -11.52% +5.18%
Other Operating Expense
- - - -
-
Unusual Expense
18.45M 48.94M 1.85M 2.71M
EBIT after Unusual Expense
(224.53M) (236.29M) (32.31M) 23.00M
Non Operating Income/Expense
633.00K 50.92M 1.23M 1.03M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
8.83M 21.22M 26.54M 11.66M
Interest Expense Growth
-63.98% +140.37% +25.05% -56.05%
Gross Interest Expense
8.83M 21.22M 26.54M 11.66M
Interest Capitalized
- - - -
-
Pretax Income
(232.73M) (206.58M) (57.61M) 12.36M
Pretax Income Growth
+30.13% +11.23% +72.11% +121.46%
Pretax Margin
-27.08% -19.57% -4.61% +0.87%
Income Tax
(17.17M) (20.32M) (170.00K) 2.70M
Income Tax - Current - Domestic
(433.00K) 1.59M 788.00K 682.00K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(16.73M) (21.91M) (958.00K) 2.02M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(215.56M) (186.26M) (57.44M) 9.66M
Minority Interest Expense
- - - -
-
Net Income
(215.56M) (186.26M) (57.44M) 9.66M
Net Income Growth
+29.83% +13.59% +69.16% +116.82%
Net Margin Growth
-25.08% -17.64% -4.59% +0.68%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(215.56M) (186.26M) (57.44M) 9.66M
Preferred Dividends
- - - -
-
Net Income Available to Common
(215.56M) (186.26M) (57.44M) 9.66M
EPS (Basic)
-0.6068 -0.5069 -0.1515 0.025
EPS (Basic) Growth
+42.22% +16.46% +70.11% +116.50%
Basic Shares Outstanding
355.28M 367.46M 379.15M 386.02M
EPS (Diluted)
-0.6068 -0.5069 -0.1515 0.0247
EPS (Diluted) Growth
+42.22% +16.46% +70.11% +116.30%
Diluted Shares Outstanding
355.28M 367.46M 379.15M 391.14M
EBITDA
(136.88M) (106.91M) 40.49M 80.46M
EBITDA Growth
+40.23% +21.90% +137.87% +98.70%
EBITDA Margin
-15.93% -10.13% +3.24% +5.65%

Snapshot

Average Recommendation BUY Average Target Price 9.722
Number of Ratings 10 Current Quarters Estimate 0.014
FY Report Date 06 / 2026 Current Year's Estimate 0.073
Last Quarter’s Earnings 0.01 Median PE on CY Estimate N/A
Year Ago Earnings 0.02 Next Fiscal Year Estimate 0.143
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 6 6 5
Mean Estimate 0.01 0.02 0.07 0.14
High Estimates 0.02 0.03 0.10 0.18
Low Estimate 0.00 0.01 0.04 0.11
Coefficient of Variance 59.40 44.02 38.15 20.17

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 8
OVERWEIGHT 1 1 1
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Lifestance Health Group Inc - LFST

Date Name Shares Transaction Value
Aug 13, 2025 Kenneth A. Burdick Director 3,414,771 Open market or private purchase of non-derivative security Non-derivative transaction at $4.36 per share 14,888,401.56
Aug 13, 2025 Kenneth A. Burdick Director 3,416,571 Open market or private purchase of non-derivative security Non-derivative transaction at $4.31 per share 14,725,421.01
Aug 13, 2025 Kenneth A. Burdick Director 3,417,991 Open market or private purchase of non-derivative security Non-derivative transaction at $4.35 per share 14,868,260.85
Aug 13, 2025 Kenneth A. Burdick Director 3,436,571 Open market or private purchase of non-derivative security Non-derivative transaction at $4.54 per share 15,602,032.34
Aug 13, 2025 Kenneth A. Burdick Director 46,511 Open market or private purchase of non-derivative security Non-derivative transaction at $4.3 per share 199,997.30

Lifestance Health Group Inc in the News